Literature DB >> 20102994

Diagnosis of pulmonary malignancy after hospitalization for pneumonia.

Eric M Mortensen1, Laurel A Copeland, Mary Jo Pugh, Michael J Fine, Brandy Nakashima, Marcos I Restrepo, Rosa Malo de Molina, Antonio Anzueto.   

Abstract

BACKGROUND: Many physicians recommend that patients receive follow-up chest imaging after the diagnosis of pneumonia to ensure that a pulmonary malignancy is not missed. However, there is little research evidence to support this practice. Our aims were to assess the frequency of the diagnosis of pulmonary malignancy, and to identify risk factors for pulmonary malignancy following hospitalization for pneumonia.
METHODS: By excluding patients with a prior diagnosis of pulmonary malignancy, we examined the incidence of a new pulmonary malignancy diagnosis in inpatients aged >/=65 years with a discharge diagnosis of pneumonia in fiscal years 2002-2007, and at least 1 year of Department of Veterans Affairs outpatient care before the index admission.
RESULTS: Of 40,744 patients hospitalized with pneumonia, 3760 (9.2%) patients were diagnosed with pulmonary malignancy after their index pneumonia admission. Median time to diagnosis was 297 days, with only 27% diagnosed within 90 days of admission. Factors significantly associated with a new diagnosis of pulmonary malignancy included history of chronic pulmonary disease, any prior malignancy, white race, being married, and tobacco use. Increasing age, Hispanic ethnicity, need for intensive care unit admission, and a history of congestive heart failure, stroke, dementia, or diabetes with complications were associated with a lower incidence of pulmonary malignancy.
CONCLUSION: A small, but clinically important, proportion of patients are diagnosed with pulmonary malignancy posthospitalization for pneumonia. Additional research is needed to examine whether previously undiagnosed pulmonary malignancies might be detected at admission, or soon after, for those hospitalized with pneumonia. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20102994      PMCID: PMC2813212          DOI: 10.1016/j.amjmed.2009.08.009

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  Pneumonia--the quality of medical records data.

Authors:  T J Marrie; H Durant; E Sealy
Journal:  Med Care       Date:  1987-01       Impact factor: 2.983

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Accuracy of administrative data for identifying patients with pneumonia.

Authors:  Dominik Aronsky; Peter J Haug; Charles Lagor; Nathan C Dean
Journal:  Am J Med Qual       Date:  2005 Nov-Dec       Impact factor: 1.852

4.  Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.

Authors:  M T van Rens; A B de la Rivière; H R Elbers; J M van Den Bosch
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

5.  Quality of care, process, and outcomes in elderly patients with pneumonia.

Authors:  T P Meehan; M J Fine; H M Krumholz; J D Scinto; D H Galusha; J T Mockalis; G F Weber; M K Petrillo; P M Houck; J M Fine
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

6.  Pneumonia and carcinoma of the lung.

Authors:  T J Marrie
Journal:  J Infect       Date:  1994-07       Impact factor: 6.072

7.  Association of pneumonia and lung cancer: the value of convalescent chest radiography and follow-up.

Authors:  H Holmberg; P Kragsbjerg
Journal:  Scand J Infect Dis       Date:  1993

8.  Use of ICD-9 coding as a proxy for stage of disease in lung cancer.

Authors:  Simu K Thomas; Sandra E Brooks; C Daniel Mullins; Claudia R Baquet; Sanjay Merchant
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-12       Impact factor: 2.890

9.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

10.  Accuracy and completeness of mortality data in the Department of Veterans Affairs.

Authors:  Min-Woong Sohn; Noreen Arnold; Charles Maynard; Denise M Hynes
Journal:  Popul Health Metr       Date:  2006-04-10
View more
  10 in total

Review 1.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

2.  Predictors of rehospitalization after admission for pneumonia in the veterans affairs healthcare system.

Authors:  Victoria L Tang; Ethan A Halm; Michael J Fine; Christopher S Johnson; Antonio Anzueto; Eric M Mortensen
Journal:  J Hosp Med       Date:  2014-03-19       Impact factor: 2.960

3.  Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD.

Authors:  Robert P Young; Raewyn J Hopkins; Chris F Whittington; Bryan A Hay; Michael J Epton; Gregory D Gamble
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

Review 4.  Previous lung diseases and lung cancer risk: a systematic review and meta-analysis.

Authors:  Darren R Brenner; John R McLaughlin; Rayjean J Hung
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

5.  Traumatic Brain Injury and Substance Related Disorder: A 10-Year Nationwide Cohort Study in Taiwan.

Authors:  Chieh-Hsin Wu; Tai-Hsin Tsai; Yu-Feng Su; Zi-Hao Zhang; Wei Liu; Ming-Kung Wu; Chih-Hui Chang; Keng-Liang Kuo; Ying-Yi Lu; Chih-Lung Lin
Journal:  Neural Plast       Date:  2016-09-27       Impact factor: 3.599

6.  Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.

Authors:  Joshua P Metlay; Grant W Waterer; Ann C Long; Antonio Anzueto; Jan Brozek; Kristina Crothers; Laura A Cooley; Nathan C Dean; Michael J Fine; Scott A Flanders; Marie R Griffin; Mark L Metersky; Daniel M Musher; Marcos I Restrepo; Cynthia G Whitney
Journal:  Am J Respir Crit Care Med       Date:  2019-10-01       Impact factor: 21.405

Review 7.  Post-Obstructive Pneumonia in Patients with Cancer: A Review.

Authors:  Kenneth V I Rolston; Lior Nesher
Journal:  Infect Dis Ther       Date:  2018-02-01

8.  Impact of coexistent chronic obstructive pulmonary disease on the survival of patients with small cell lung cancer receiving chemotherapy.

Authors:  Sunmi Ju; Hyang Rae Lee; Ju-Young Kim; Ho Cheol Kim; Gyeong-Won Lee; Jung Wan You; Yu Ji Cho; Yi Yeong Jeong; Jong Deog Lee; Seung Jun Lee
Journal:  Thorac Cancer       Date:  2018-08-14       Impact factor: 3.500

9.  The prognosis of non-small cell lung cancer combined with chronic obstructive pulmonary disease: A systematic review and meta-analysis.

Authors:  Ke Wu; Jing Wang; Limin Zhao; Pei Wang; Qi Duan
Journal:  Clin Respir J       Date:  2020-02-03       Impact factor: 2.570

10.  Chronic obstructive pulmonary disease and risk of lung cancer: a meta-analysis of prospective cohort studies.

Authors:  Xinyue Zhang; Ning Jiang; Lijuan Wang; Huaman Liu; Rong He
Journal:  Oncotarget       Date:  2017-08-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.